Lessons from COVID reveal how monopoly power in the biopharmaceutical industry is evolving

In his latest paper, Politics Professor Matt Sparke and his coauthor use the case of COVID to demonstrate both the enduring problem of bio-pharmaceutical monopolies and the ways they have been extended and entrenched through complex market-state interconnections.